Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, 35294, United States.
Eur J Pharmacol. 2011 Jun 11;660(1):125-30. doi: 10.1016/j.ejphar.2010.12.020. Epub 2011 Jan 3.
Melanocortin receptors belong to the seven-transmembrane (TM) domain proteins that are coupled to G-proteins and signaled through intracellular cyclic adenosine monophosphate. Many structural features conserved in other G-protein coupled receptors (GPCRs) are found in the melanocortin receptors. There are five melanocortin receptor subtypes and each of the melanocortin receptor subtypes has a different pattern of tissue expression and has its own profile regarding the relative potency of different melanocortin peptides. α-, β-, and γ-MSH and ACTH are known endogenous agonist ligands for the melanocortin receptors. Agouti and AgRP are the only known naturally occurring antagonists of the melanocortin receptors. We have examined the molecular basis of all five human melanocortin receptors for different ligand binding affinities and potencies using chimeric and mutated receptors. Our studies indicate that human melanocortin MC(1) receptor, human melanocortin MC(3) receptor, human melanocortin MC(4) receptor and human melanocortin MC(5) receptor utilize orthosteric sites for non selective agonists, α-MSH and NDP-α-MSH, high affinity binding and utilize allosteric sites for selective agonist or antagonist binding. Furthermore, our results indicate that molecular determinants of human melanocortin MC(2) receptor for ACTH binding and signaling are different from that of other melanocortin receptors. Many studies also indicate that agonists can induce different conformation changes of melanocortin receptors, which then lead to the activation of different signaling pathways, even when the expression level of receptor and the strength of stimulus-response coupling are the same. This finding may provide new information for the design of drugs for targeting melanocortin receptors.
黑素细胞刺激素受体属于七跨膜 (TM) 域蛋白,与 G 蛋白偶联并通过细胞内环磷酸腺苷 (cAMP) 信号转导。许多在其他 G 蛋白偶联受体 (GPCR) 中保守的结构特征在黑素细胞刺激素受体中都有发现。有五种黑素细胞刺激素受体亚型,每种黑素细胞刺激素受体亚型的组织表达模式不同,并且对不同黑素细胞刺激素肽的相对效力具有自己的特征。α-、β-和 γ-MSH 和 ACTH 是已知的黑素细胞刺激素受体的内源性激动剂配体。Agouti 和 AgRP 是已知的黑素细胞刺激素受体的唯一天然拮抗剂。我们使用嵌合和突变受体研究了所有五种人类黑素细胞刺激素受体对不同配体结合亲和力和效力的分子基础。我们的研究表明,人类黑素细胞刺激素 MC(1)受体、人类黑素细胞刺激素 MC(3)受体、人类黑素细胞刺激素 MC(4)受体和人类黑素细胞刺激素 MC(5)受体利用正位点与非选择性激动剂、α-MSH 和 NDP-α-MSH 进行高亲和力结合,并利用变构位点进行选择性激动剂或拮抗剂结合。此外,我们的结果表明,人类黑素细胞刺激素 MC(2)受体与 ACTH 结合和信号转导的分子决定因素与其他黑素细胞刺激素受体不同。许多研究还表明,激动剂可以诱导黑素细胞刺激素受体发生不同的构象变化,从而激活不同的信号通路,即使受体的表达水平和刺激-反应偶联强度相同。这一发现可能为针对黑素细胞刺激素受体的药物设计提供新信息。